Bill

Bill > H7075


RI H7075

RI H7075
Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.


summary

Introduced
01/14/2026
In Committee
01/14/2026
Crossed Over
Passed
Dead

Introduced Session

2026 Regular Session

Bill Summary

This act would require, commencing January 1, 2027, group health plans and health insurance issuers that provide prescription benefits to cover at least one type of glucagon auto- injector, nasal spray, or formulation which does not require reconstitution to treat hypoglycemia with two (2) glucagon auto-injectors every plan year. No copayment or deductible would be required to obtain prescribed glucagon medications. This act would take effect upon passage.

AI Summary

This bill mandates that starting January 1, 2027, all health plans and insurance policies in Rhode Island that cover prescription drugs must also cover at least one type of glucagon product, such as an auto-injector or nasal spray, that is ready to use without needing to be mixed beforehand (reconstitution) to treat hypoglycemia, which is a condition of dangerously low blood sugar. This coverage will require no out-of-pocket costs for patients, meaning no copayments or deductibles will be applied when obtaining two units of these glucagon products per plan year, although a deductible may still apply to health plans linked to federally qualified health savings accounts. The bill also notes that health plans can implement this coverage earlier than the January 1, 2027 deadline and will take effect upon its passage.

Committee Categories

Health and Social Services

Sponsors (9)

Last Action

Committee recommended measure be held for further study (on 01/29/2026)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...